将后生物质纳入控制肥胖的干预措施
Emília Hijová1, Izabela Bertková1, Jana Štofilová1
1Center of Clinical and Preclinical Research-MediPark, Faculty of Medicine, Pavol Jozef Šafárik University, SNP 1, 040 11 Košice, Slovakia.
International journal of molecular sciences
|June 13, 2025
概括
来自益生菌的后生物,通过利用有益的微生物成分,为控制肥胖提供了一个有希望的策略. 需要进一步的研究,以充分了解它们的机制,并优化它们的整合到健康干预.
科学领域:
- 微生物学 微生物学
- 代谢健康 代谢健康
- 肠道微生物组研究研究
背景情况:
- 肥胖是一种全球性流行病,对健康和社会造成重大负担.
- 改变的肠道微生物群与疾病的发病有关,产生有益的代谢物.
- 来自益生菌的后生物质是具有治疗潜力的生物活性成分.
研究的目的:
- 为了提供一个全面的概述后生物的健康益处,专注于肥胖管理.
- 为了突出后生物作为一种可行的策略,对肥胖没有活细菌.
- 强调对后生物机制进行进一步研究的必要性.
主要方法:
- 关于后生物和肥胖的当前研究的文献综述.
- 分析肠道微生物群代谢物在健康中的作用.
- 探索后生物药物作为一种治疗替代品.
主要成果:
- 后生物药物显示出管理肥胖和改善健康结果的潜力.
- 在某些应用中,它们代表了益生菌的有希望的替代品.
- 目前对机制和特定组件作用的理解需要进一步研究.
结论:
- 后生物质药物为提高预防护理和控制肥胖提供了显著的潜力.
- 进一步的研究对于阐明特定机制和优化其使用至关重要.
- 将后生物质纳入健康干预措施可以改善风险人群的结果.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management
134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
134
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Irritable Bowel Syndrome III: Medical and Nursing Management
188
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
188
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Binge Eating Disorders
58
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
58


